Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
102 participants
INTERVENTIONAL
2022-02-18
2025-10-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Postoperative Analgesia in Patients Undergoing Open Upper Abdominal Surgeries: External Oblique Intercostal Plane Block vs. Quadratus Lumborum Block
NCT07094386
Comparison Between Erector Spinae Plane Block And Retrolaminar Block In Patients Undergoing VATS.
NCT06021327
SPSIPB Versus Deep SAPB for Analgesia After Breast Surgery
NCT06436599
Modified Versus Conventional Serratus Anterior Plane Block
NCT05661253
Bilateral Ultrasound Guided Quadratus Lumborum Versus Lumbar Epidural Block on Postoperative Analgesia, and Inflammatory Response in Abdominal Surgery
NCT03958942
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Adequate postoperative pain relief is imperative to hasten functional recovery, accelerate discharge from the hospital, and reduce chronic postsurgical pain.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group I
Patients will receive ultrasound-guided deep serratus anterior plane block.
Ultrasound-guided deep serratus anterior plane block with isobaric bupivacaine
Patients will receive ultrasound-guided deep serratus anterior plane block with isobaric bupivacaine.
Group II
Patients will receive local wound infiltration (LWI).
Local wound infiltration with isobaric bupivacaine
Patients will receive local wound infiltration with isobaric bupivacaine.
Group III
Patients will receive ultrasound-guided thoracic paravertebral block.
Ultrasound-guided thoracic paravertebral block with isobaric bupivacaine
Patients will receive ultrasound-guided thoracic paravertebral block with isobaric bupivacaine.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ultrasound-guided deep serratus anterior plane block with isobaric bupivacaine
Patients will receive ultrasound-guided deep serratus anterior plane block with isobaric bupivacaine.
Local wound infiltration with isobaric bupivacaine
Patients will receive local wound infiltration with isobaric bupivacaine.
Ultrasound-guided thoracic paravertebral block with isobaric bupivacaine
Patients will receive ultrasound-guided thoracic paravertebral block with isobaric bupivacaine.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Pregnancy
* Body mass index (BMI) \> 30 Kg/m2
* Psychiatric diseases
* Severe renal, liver, or cardiac dysfunction
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Seham Mohamed Moeen Ibrahim
Assistant professor of Anesthesia and Intensive Care
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Seham M Moeen, MD
Role: PRINCIPAL_INVESTIGATOR
Assiut University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seham M. Moeen
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
10 2021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.